A critical advance in cancer study is arising with the use of VHH fragments to reactivate mutated p53. This essential malignant suppressor protein is frequently lost in several kinds of malignancies, resulting https://adsbookmark.com/story22068149/mini-antibodies-reactivate-the-p53-protein-new-potential-hope-for-malignant-management